Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

We have observed 3 EP applications Lucy Rose Hitchcock has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after May 6, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP14760330

HOST CELLS AND METHODS OF USE

IPC classification:
C07K 14/395
Applicant:
GlaxoSmithKline LLC
Agent:
Lucy Rose Hitchcock, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15190050

METHODS AND COMPOSITIONS FOR USE IN TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) PATIENTS WITH AUTOANTIBODY POSITIVE DISEASES

IPC classification:
A61K 39/395, A61K 49/00, C07H 21/04, C07K 16/00, C12P 21/06
Agent:
Lucy Rose Hitchcock, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP16167794

METHODS FOR ADMINISTERING HYPOGLYCEMIC AGENTS

IPC classification:
A61K 38/26, B05B 11/00
Applicant:
GlaxoSmithKline LLC
Agent:
Lucy Rose Hitchcock, GlaxoSmithKline
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature